subject: Current Trends And Issues In The Singapore Pharmaceutical Industry [print this page] Singapore Pharmaceutical Industry 2H10 Singapore Pharmaceutical Industry 2H10
Singapore: Pharmaceutical covers the Asia Pacific overview, Singapore overview, production, principal statistics of pharmaceutical industry in Singapore and foreign trade. It also covers the market trends and outlook, regulatory bodies, SWOT Analysis of the Pharmaceutical Market, investment in the market including GlaxoSmithKline Green Manufacturing, Abbott Nutrition R&D Center, Pfizer Nutrition Plant Expansion and Roche Biologics Manufacturing Plant, plus the leading players in the industry, comparative matrix and SWOT analysis: Tianjin Zhong Xin Pharmaceutical Group, Eu Yan Sang International Limited, Reyoung Pharmaceutical Holdings Limited, Luye Pharma Group Limited and Haw Paw Corporation Limited. ( http://www.bharatbook.com/detail.asp?id=150348&rt=Singapore-Pharmaceutical-Industry-2H10.html )
Executive Summary
SG Pharmaceutical includes an overview of the pharmaceutical industry in Singapore, one of the fast expanding industries in the countrys economy, estimated to hit a value of USD596.0 million (USD119 per capita) by end of 2010. Part 1 of the report also contains Singapores pharmaceutical production, as well as the countrys imports and exports of chemical and chemical products. It gives a brief introduction of the R&D councils and related ministries in Singapore, along with its core research centre, namely Biopolis.
The second part of the report includes current trends and issues in the Singapore chemical industry, including the regulatory bodies in the industry, a SWOT analysis of the pharmaceutical industry as a whole, intellectual property rights, the rise in the generic drug market, as well as a list of the new investments in the pharmaceutical industry. Companies to set up new investments are namely GlaxoSmithKline, Abbott, Pfizer and Roche. It also includes an outlook on the industry.
A ranking of the major in the industry would also be provided in the third part of the report. Current leading players in the market include Tianjin Zhong Xin, Eu Yan Sang, Reyoung, Luye and Haw Par. This part also includes a comparative matrix of the financial highlights of the companies. A SWOT analysis of the companies can also be found in this part of the report.
For more information kindly visit : http://www.bharatbook.com/detail.asp?id=150348&rt=Singapore-Pharmaceutical-Industry-2H10.html
